Viewing Study NCT05547061


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2025-12-27 @ 9:25 PM
Study NCT ID: NCT05547061
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-11
First Post: 2022-09-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy
Sponsor: Cellbion Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module